000 | 01909 a2200601 4500 | ||
---|---|---|---|
005 | 20250517205048.0 | ||
264 | 0 | _c20180830 | |
008 | 201808s 0 0 eng d | ||
022 | _a1471-2407 | ||
024 | 7 |
_a10.1186/s12885-018-4190-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLynch, Julie A | |
245 | 0 | 0 |
_aUnderutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013. _h[electronic resource] |
260 |
_bBMC cancer _c03 2018 |
||
300 |
_a306 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDiagnostic Tests, Routine _xmethods |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHealth Services Accessibility _xstatistics & numerical data |
650 | 0 | 4 | _aHealth Status Disparities |
650 | 0 | 4 |
_aHealthcare Disparities _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMedicare |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPrecision Medicine |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBerse, Brygida | |
700 | 1 | _aRabb, Merry | |
700 | 1 | _aMosquin, Paul | |
700 | 1 | _aChew, Rob | |
700 | 1 | _aWest, Suzanne L | |
700 | 1 | _aCoomer, Nicole | |
700 | 1 | _aBecker, Daniel | |
700 | 1 | _aKautter, John | |
773 | 0 |
_tBMC cancer _gvol. 18 _gno. 1 _gp. 306 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-018-4190-3 _zAvailable from publisher's website |
999 |
_c28194279 _d28194279 |